ABBV files for FDA approval of tavapadon, a once-daily oral Parkinson's drug backed by late-stage TEMPO studies.
Currently, seven CAR T-cell therapies 1 and six T-cell engager therapies have been approved by the FDA. 2 Despite these advancements and their clear benefits, immunotherapy-based treatments carry ...
Technology Excellence Awards held at Pack Expo Las Vegas 2025 spotlight innovations redefining packaging and processing.
RedChip Companies will air interviews with BioVie Inc. (NASDAQ:BIVI) and FibroBiologics, Inc. (Nasdaq:FBLG) on the RedChip ...
Ondas offers high-risk, high-reward potential. See why I remain cautious until ONDS stock demonstrates sustainable, ...
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...
CARSON CITY, Nev., Sept. 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and ...
Less than three months into the fiscal year, Gov. Ned Lamont’s administration has identified major cost overruns in CT's ...
The Prince of Wales Hospice in Pontefract recently welcomed MP Yvette Cooper and representatives from the Morrisons Foundation for a special presentation and tour of the hospice’s newly enhanced ...
IAM provider Descope has announced raising $35 million in a seed funding extension that brings the total raised by the ...
With Serenara Wellness, Yewande is rewriting the narrative of midlife health in Nigeria. Blending medical expertise with ...